All Stories

  1. Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target
  2. An extended transcription factor regulatory network controls hepatocyte identity
  3. Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells
  4. Oral exposure to polyethylene microplastics alters gut morphology, immune response, and microbiota composition in mice
  5. Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist
  6. Starch-based NP act as antigen delivery systems without immunomodulating effect
  7. MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes
  8. Murine in utero exposure to simulated complex urban air pollution disturbs offspring gut maturation and microbiota during intestinal suckling-to-weaning transition in a sex-dependent manner
  9. Exposure to atmospheric Ag, TiO2, Ti and SiO2 engineered nanoparticles modulates gut inflammatory response and microbiota in mice
  10. The PPARγ-dependent effect of flavonoid luteolin against damage induced by the chemotherapeutic irinotecan in human intestinal cells
  11. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis
  12. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
  13. The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy
  14. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis
  15. Luteolin prevents irinotecan‐induced intestinal mucositis in mice through antioxidant and anti‐inflammatory properties
  16. Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response
  17. A Novel Mouse Model of Acute‐on‐Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis
  18. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
  19. Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
  20. Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules
  21. Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis
  22. Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses
  23. β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway
  24. Cholesterol-enriched membrane microdomains are needed for insulin signaling and proliferation in hepatic cells
  25. High carriage of adherent invasive E. coli in wildlife and healthy individuals
  26. Cross regulation between mTOR signaling and O-GlcNAcylation
  27. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis
  28. Neoboutonia melleri var velutina Prain: in vitro and in vivo hepatoprotective effects of the aqueous stem bark extract on acute hepatitis models
  29. One- or Two-Step Synthesis of C-8 and N-9 Substituted Purines
  30. Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
  31. The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis
  32. Chronic bowel inflammation and inflammatory joint disease: Pathophysiology
  33. Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination
  34. Whole transcriptome analysis of ductular reaction from patients with alcoholic hepatitis. Similarities to ductular reaction in DDC mouse model
  35. Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease
  36. Microbiote intestinal et développement des maladies inflammatoires chroniques de l’intestin
  37. Periodontal manifestations of inflammatory bowel disease: emerging epidemiologic and biologic evidence
  38. Erratum: Corrigendum: Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn’s Disease Patients
  39. Inflammation chronique de l’intestin et rhumatismes inflammatoires : physiopathologie
  40. Short fungal fractions of β-1,3 glucans affect platelet activation
  41. Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn’s Disease Patients
  42. MicroRNA in alcoholic hepatitis: implications for pathophysiology and treatment
  43. Tu1881 HLA B27 Transgenic Rat: A New Animal Model of Postsurgical Ileitis in Inflammatory Bowel Disease
  44. Sa1866 Mesenteric Lymphatic and Venous Vasculopathy in Crohn's Disease
  45. 979 Modulating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ): A Potential New Therapeutic Strategy for Lactose Intolerance
  46. Mo1923 Polymorphisms in the Mannose Binding Lectin Gene Are Associated With the Defect of the Mannose Binding Lectin Functional Activity in Crohn's Disease Patients
  47. Sa1846 The Expression of the Short Isoform of TSLP in the Colon Is Regulated by the Nuclear Receptor PPARγ and Is Impaired During Ulcerative Colitis
  48. Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis
  49. Intestinal steroidogenesis
  50. Role of mannose-binding lectin in intestinal homeostasis and fungal elimination
  51. Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance
  52. The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils
  53. Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier
  54. Escherichia coli LF82 Differentially Regulates ROS Production and Mucin Expression in Intestinal Epithelial T84 Cells
  55. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis
  56. In vivo efficacy of microbiota-sensitive coatings for colon targeting: A promising tool for IBD therapy
  57. Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration
  58. Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis
  60. P084 Dissecting the role of PPARgamma in intestinal fibrosis: EMT-activator ZEB1 as new molecular target
  61. ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading
  62. Functional Polymorphisms in the Regulatory Regions of the VNN1 Gene Are Associated with Susceptibility to Inflammatory Bowel Diseases
  63. Decreased Lymphatic Vessel Density Is Associated With Postoperative Endoscopic Recurrence in Crohn’s Disease
  64. The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
  65. Colonic Inflammation in Mice Is Improved by Cigarette Smoke through iNKT Cells Recruitment
  66. In vivoimaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice
  67. Modulation of Intestinal Inflammation by Yeasts and Cell Wall Extracts: Strain Dependence and Unexpected Anti-Inflammatory Role of Glucan Fractions
  68. Variants of NOD1 and NOD2 genes display opposite associations with familial risk of crohnʼs disease and anti-saccharomyces cerevisiae antibody levels
  69. Visceral fat and gut inflammation
  70. Murine Model of Dextran Sulfate Sodium-induced Colitis RevealsCandida glabrataVirulence and Contribution of β-Mannosyltransferases
  71. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
  72. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease
  73. Obesity, visceral fat and Crohnʼs disease
  74. 274 Sacharomyces Cerevisiae Cncm I-3856 Decreases Intestinal Pain Through PPAR Alpha Activation in the Gut
  75. Neutrophil Migration During Liver Injury Is Under Nucleotide-Binding Oligomerization Domain 1 Control
  76. PPARγ agonists as a new class of effective treatment for ulcerative colitis
  77. Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
  78. Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
  79. Resistin-like molecule β regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice
  80. Récepteurs nucléaires PPAR et hépatologie : implications physiopathologiques et thérapeutiques
  81. NOD2: a potential target for regulating liver injury
  83. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease
  85. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
  86. PPAR  as a new therapeutic target in inflammatory bowel diseases
  87. The nuclear receptor LRH-1 critically regulates extra-adrenal glucocorticoid synthesis in the intestine
  88. No Evidence for an Involvement of the P38 and JNK Mitogen-Activated Protein in Inflammatory Bowel Diseases
  89. Implication of TNF-Related Apoptosis-Inducing Ligand in Inflammatory Intestinal Epithelial Lesions
  90. Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity
  91. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ
  92. Impaired expression of the peroxisome proliferator–activated receptor alpha during hepatitis C virus infection
  93. Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation
  94. Yersinia pseudotuberculosis Anti-Inflammatory Components Reduce Trinitrobenzene Sulfonic Acid-Induced Colitis in the Mouse
  95. Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis
  96. Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases
  97. A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
  98. Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer